You are here

Pharmaceuticals and Healthcare

The business of vital innovation

The pharmaceutical and healthcare sector is one of the world’s most vital and innovative.

Against a backdrop of technological change and an increasing and aging population, we partner with our clients to help them achieve their goals, capitalise on opportunities and navigate uncertainty.

Combining deep scientific, technical and strategic knowledge we help our clients by providing the commercial nous, experience and range of services that only a large international professional services firm can offer, to anticipate and deliver innovative and value-enhancing solutions.

Recent Experience

Indivior plc

in connection with the Relationship Agreement and settlement reached with the Company’s largest shareholder, the activist investor Scopia Management

Parkinson's UK

on its acquisition of assets relating to the research, development, manufacture and marketing of glial-cell line-derived neurotrophic factor (GDNF), a potentially disease-modifying treatment for Parkinson's disease

SK Holdings

on its acquisition of Yposkesi, a French market leader in gene therapy and viral vector manufacturing

Acacia Research Corporation

on its entry into an agreement with Link Fund Solutions Limited to purchase shares in up to 19 public and private life sciences companies from the LF Equity Income Fund for up to £223.9 million.

FederFARMACO

a company representing pharmaceutical wholesalers, on regulatory affairs and intellectual property matters

Mirnagreen

 in relation to the launch and correct classification of new products based on a disruptive technology for extracting microRNA from plants, including advising on strategy to mitigate risks related to a misclassification under the contiguous categories of medicinal products, novel food and food supplements

Insights and updates

6th October 2022
In the area of patent law, clarity is king. Where precision of language is essential...
19th August 2022
On 18 August 2022, the Commonwealth Government released draft legislation proposing five-fold increases in the...
25th March 2022
Last week, a Full Court of the Federal Court of Australia handed down two unanimous...
18th November 2021
‘Cyber-ransoms’ are on the rise, and with new cyber tactics and ways of working, the...

Related news and deals

18 November 2022

Herbert Smith Freehills and Hiswara Bunjamin & Tandjung advise Silk Road Fund on investment in Indonesian pharmaceutical SOEs 史密夫斐尔及Hiswara Bunjamin & Tandjung为丝路基金投资印尼国有制药企业提供法律咨询

08 November 2022

Herbert Smith Freehills advises CICC as the sole sponsor on LEPU ScienTech's Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人中金公司律师为乐普心泰医疗香港上市提供法律服务

10 October 2022

Herbert Smith Freehills advises sponsors on Jenscare's Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为健世科技香港上市提供法律服务

01 September 2022

Herbert Smith Freehills advises sponsors on Biocytogen Pharmaceuticals' Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为百奥赛图香港上市提供法律服务